Mary Motyl

Best Publications

• Platensimycin is a selective FabF inhibitor with potent antibiotic properties

  Jun Wang;Stephen M. Soisson;Katherine Young;Wesley Shoop;Wesley Shoop

  1001
  Citations

• Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties.

  Jun Wang;Srinivas Kodali;Sang Ho Lee;Andrew Galgoci

  465
  Citations

• Clinical breakpoints for the echinocandins and Candida revisited: Integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria

  M.A. Pfaller;D.J. Diekema;D. Andes;M.C. Arendrup

  377
  Citations

• Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial.

  Johan A Maertens;Galia Rahav;Galia Rahav;Dong-Gun Lee;Alfredo Ponce-de-León

  252
  Citations

• Interlaboratory Comparison of Results of Susceptibility Testing with Caspofungin against Candida and Aspergillus Species

  Frank C. Odds;Mary Motyl;Roberto Andrade;Jacques Bille

  200
  Citations

• Caspofungin Susceptibility Testing of Isolates from Patients with Esophageal Candidiasis or Invasive Candidiasis: Relationship of MIC to Treatment Outcome

  Unknown

  188
  Citations

• Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methods.

  M. A. Pfaller;D. J. Diekema;M. A. Ghannoum;J. H. Rex

  185
  Citations

• Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria.

  Michael A. Pfaller;David Andes;Maiken C. Arendrup;Daniel J. Diekema

  179
  Citations

• Global Escherichia coli Sequence Type 131 Clade with blaCTX-M-27 Gene.

  Yasufumi Matsumura;Johann D.D. Pitout;Ryota Gomi;Tomonari Matsuda

  178
  Citations

• Global distribution and outcomes for Candida species causing invasive candidiasis: results from an international randomized double-blind study of caspofungin versus amphotericin B for the treatment of invasive candidiasis.

  A. L. Colombo;J. Perfect;M. DiNubile;K. Bartizal

  171
  Citations

• In Vitro Activity of MK-7655, a Novel β-Lactamase Inhibitor, in Combination with Imipenem against Carbapenem-Resistant Gram-Negative Bacteria

  Elizabeth B. Hirsch;Kimberly R. Ledesma;Kai Tai Chang;Michael S. Schwartz

  169
  Citations

• In Vitro Activity of Imipenem-Relebactam against Gram-Negative ESKAPE Pathogens Isolated by Clinical Laboratories in the United States in 2015 (Results from the SMART Global Surveillance Program).

  Sibylle H. Lob;Meredith A. Hackel;Krystyna M. Kazmierczak;Katherine Young

  166
  Citations

• Genomic Epidemiology of Global Carbapenemase-Producing Enterobacter spp., 2008-2014.

  Gisele Peirano;Yasufumi Matsumura;Mark D. Adams;Patricia Bradford

  150
  Citations

• Enfumafungin Derivative MK-3118 Shows Increased In Vitro Potency against Clinical Echinocandin-Resistant Candida Species and Aspergillus Species Isolates

  Cristina Jiménez-Ortigosa;Padmaja Paderu;Mary R. Motyl;David S. Perlin

  142
  Citations

• In Vitro Activity of a New Oral Glucan Synthase Inhibitor (MK-3118) Tested Against Aspergillus spp. by CLSI and EUCAST Broth Microdilution Methods

  Michael A. Pfaller;Shawn A. Messer;Mary R. Motyl;Ronald N. Jones

  118
  Citations

• Bowel colonization with resistant gram-negative bacilli after antimicrobial therapy of intra-abdominal infections: observations from two randomized comparative clinical trials of ertapenem therapy

  M. J. DiNubile;I. Friedland;C. Y. Chan;M. R. Motyl

  117
  Citations

• Activity of MK-3118, a new oral glucan synthase inhibitor, tested against Candida spp. by two international methods (CLSI and EUCAST)

  Michael A Pfaller;Shawn A Messer;Mary R Motyl;Ronald N Jones

  117
  Citations

• In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa

  Katherine Young;Ronald E. Painter;Susan L. Raghoobar;Nichelle N. Hairston

  115
  Citations

• Genomic epidemiology of global Klebsiella pneumoniae carbapenemase (KPC)-producing Escherichia coli.

  N. Stoesser;A.E. Sheppard;G. Peirano;L.W. Anson

  114
  Citations

• In Vitro Activity of Imipenem against Carbapenemase-Positive Enterobacteriaceae Isolates Collected by the SMART Global Surveillance Program from 2008 to 2014

  James A. Karlowsky;Sibylle H. Lob;Krystyna M. Kazmierczak;Robert E. Badal

  111
  Citations